Surgical Site Infection Management

Introduction to Antibiotic Therapy

Clindamycin offers good coverage against gram-positive organisms and anaerobes, making it a suitable alternative for surgical site infections, as recognized by the American College of Surgeons and other guideline societies 1, 2
The choice of antibiotic should be tailored to the specific surgical site, with consideration of the patient's medical history and potential allergies 3

For more severe infections, the recommended IV dosing of Clindamycin is 600-900 mg IV every 8 hours 2
Vancomycin is recommended for MRSA risk or β-lactam allergy, at a dose of 15-20 mg/kg every 8-12 hours, by the Clinical Infectious Diseases guidelines 4
Linezolid is also recommended for MRSA risk or β-lactam allergy, at a dose of 600mg IV/PO every 12 hours, by the Clinical Infectious Diseases guidelines 4

Clindamycin plus gentamicin may be preferred for better gram-negative coverage, especially in cases where mixed infection is suspected 3
Consider adding gram-negative coverage, such as gentamicin, to Clindamycin for optimal treatment outcomes 2
Ciprofloxacin (500-750mg PO BID) + Metronidazole (500mg PO TID) or levofloxacin (750mg PO daily) + Metronidazole (500mg PO TID) is recommended for excellent coverage of gram-negative and anaerobic bacteria commonly found in abdominal infections, as suggested by the Infectious Diseases Society of America 5

For suspected or confirmed MRSA infections, Vancomycin or Linezolid is a recommended alternative therapy 1, 4
Trimethoprim-sulfamethoxazole (TMP-SMX) (1-2 DS tablets BID) and doxycycline (100 mg BID) are effective for MRSA but have limited activity against β-hemolytic streptococci, according to the Infectious Diseases Society of America 6

The treatment duration for surgical site infections is typically 7-14 days, but may extend to 2-6 weeks for complicated infections, and should be guided by clinical response and resolution of infection signs 2, 3, 7, 4
Patients should be monitored for signs of C. difficile-associated diarrhea and liver enzyme function, especially those with severe liver disease 1, 2
Incision and drainage is the cornerstone of treatment for surgical site infections, and should not be delayed, recommended by the American Urological Association and the American Academy of Orthopaedic Surgeons 4, 8, 9
Thorough irrigation with normal saline and debridement of all necrotic tissue are critical components of surgical intervention, recommended by the American Urological Association and the American Academy of Orthopaedic Surgeons 8, 10, 9
Drug susceptibility results of isolated organisms should guide antibiotic selection, as recommended by the Infectious Diseases Society of America 5
Local resistance patterns should be considered when selecting empiric therapy, and TMP-SMX, doxycycline, or clindamycin may be used as empiric therapy, recommended by the American Urological Association and the Infectious Diseases Society of America 6, 9

Infection Type	Recommended Treatment
Incisional surgical site infections after intestinal or genitourinary surgery	Single-drug therapy with piperacillin-tazobactam, ticarcillin-clavulanic acid, or carbapenems, or combination therapy with ceftriaxone plus metronidazole or fluoroquinolone plus metronidazole
Incisional surgical site infections after trunk or extremity surgery	Oxacillin, nafcillin, cefazolin, cefalexin, sulfamethoxazole-trimethoprim, or vancomycin
Incisional surgical site infections after axilla or perineum surgery	Ceftriaxone or fluoroquinolone plus metronidazole

Avoid prolonged prophylactic antibiotics as they do not prevent SSIs and may contribute to resistance, according to the Anaesthesia and the Infectious Diseases Society of America 2, 11
Inadequate source control: oral antibiotics alone are insufficient without proper surgical drainage of the infection, and ensure adequate source control before transitioning to oral therapy, as recommended by the Infectious Diseases Society of America 5
Resistant organisms: consider local resistance patterns when selecting empiric therapy, and if cultures reveal organisms only susceptible to IV therapy, outpatient parenteral therapy may be necessary, as suggested by the Infectious Diseases Society of America 5
Prolonged therapy: unnecessarily prolonged antibiotic therapy increases the risk of Clostridium difficile colitis, selection of resistant organisms, and drug toxicities, according to the Infectious Diseases Society of America 5
Fluoroquinolone considerations: risk of tendinopathy, peripheral neuropathy, and aortic aneurysm, and avoid in pregnancy and children when possible 5